Showing 1 - 14 results of 14 for search 'Ching-Liang Ho', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia by Sheng-Cheng Wu, Shiue-Wei Lai, Xin-Jie Lu, Hsing-Fan Lai, Yu-Guang Chen, Po-Huang Chen, Ching-Liang Ho, Yi-Ying Wu, Yi-Lin Chiu
Published 2023-07-01
Article -
9
Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin by Sheng-Yao Cheng, Alexander T. H. Wu, Gaber El-Saber Batiha, Ching-Liang Ho, Jih-Chin Lee, Halimat Yusuf Lukman, Mohammed Alorabi, Abdullah N. AlRasheedi, Jia-Hong Chen
Published 2022-02-01
Article -
10
Immune killer cells treatment for previously treated stage IV NSCLC patients by Yen-Han Tseng, Ching-Liang Ho, Chih-Feng Chian, Chi-Lu Chiang, Heng-Sheng Chao, Chen-Liang Tsai, Wann-Cherng Perng, Chin-Fu Hsiao, Mei-Hsing Chuang, Kai-Hsiung Ko, Yun-Ching Cheng, Shin-Jung Chen, Chia-Jen Wang, Yuh-Min Chen
Published 2024-08-01
Article -
11
Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target thera... by Ming-Lang Shih, Bashir Lawal, Bashir Lawal, Sheng-Yao Cheng, Janet O. Olugbodi, Ahmad O Babalghith, Ching-Liang Ho, Simona Cavalu, Gaber El-Saber Batiha, Sarah Albogami, Saqer S. Alotaibi, Jih-Chin Lee, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu
Published 2022-08-01
Article -
12
Registry of Genetic Alterations of Taiwan Non–Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521... by Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Yang
Published 2024-09-01
Article -
13
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study by Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai, Chuan-Cheng Wang, Ming-Tsan Lin, Chun-Fu Ting, De-Chuan Chan, Te-Hung Chen, Chueh-Chuan Yen, Yen-Yang Chen, Hsuan-Yu Lin, Ta-Sen Yeh, Ching-Liang Ho, Tze-Yu Shieh, Li-Yaun Bai, Jun-Te Hsu, I-Shu Chen, Li-Tzong Chen, Chun-Nan Yeh, Taiwan Cooperative Oncology Group (TCOG) GIST Study Group
Published 2024-07-01
Article -
14
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE) by Chee Khoon Lee, PhD, Bin-Chi Liao, MD, Shalini Subramaniam, MMed (Clin Epi), Chao-Hua Chiu, MD, Antony J. Mersiades, MMed (Clin Epi), Chao-Chi Ho, MD, PhD, Chris Brown, MBiostats, Chun-Liang Lai, MD, PhD, Brett G.M. Hughes, M.B.B.S. (Hons), Tsung-Ying Yang, MD, PhD, Ken O’Byrne, MD, Yung-Hung Luo, MD, PhD, Sonia Yip, PhD, Ching-Liang Ho, MD, Victoria Bray, PhD, Wu-Chou Su, MD, PhD, Melissa Moore, PhD, Wei-Lien Feng, MS, Ya-Ying Bai, MS, Kate Ford, MHSc, Michelle M. Cummins, PhD, Martin R. Stockler, MSc (Clin Epi), Benjamin J. Solomon, PhD, Thomas John, PhD, James Chih-Hsin Yang, MD, PhD
Published 2025-02-01
Article